News

Check-Points appoints BD as distributor for Check-Points' BD MAX CPE assays outside of the United States and the Netherlands

As of 1 August 2016 the two CE-IVD assays listed below will be available through BD outside of the United States and the Netherlands.
Please note that Check-Direct ESBL Screen for BD MAXTM (Check-Points catalog number 18-0066) will be available directly through Check-Points as of 1 August 2016.

BD Catalog Numbe... Read on

Share your best #CPEadvice at ECCMID booth 268

Are you curious to learn how CPE is controlled in different hospitals around the world? Do you have best practices that have worked well in your healthcare setting?

Share your best advice to control CPE at our booth at ECCMID in Copenhagen, 25-28 April - and you'll receive an Read on

Check-Points Health’s rapid “superbug” screening assay demonstrates high accuracy in Belgian multicenter evaluation

Wageningen, The Netherlands, March 16, 2015 – Check-Points Health B.V. today announced new data from a Belgian clinical multicenter study1 demonstrating that its Check-Direct CPE assay is 100% sensitive in identifying patients colonized with so called “superbugs”. Such rapidly emerging bacteria, named carbapenemase-producing Enterobacteriaceae or CPE, threaten to seriously u...

Read on

Check-Points Health’s microarray assay finds more antibiotic resistance genes than conventional molecular techniques, recent study shows

Wageningen, The Netherlands, February 9, 2015 – Within a period of just three years carbapenem resistance in Klebsiella pneumoniae has nearly doubled in the EU from 4.6% in 2010 to 8.3% in 2013 according to a press release issued last November by the European Centre for Disease Prevention and Control (ECDC)1. Check-Points Health B.V. today releases data demonstrating how one...

Read on

Bergman Diagnostika AS new distributor in Norway

We are very pleased to announce that Bergman Diagnostika AS is our new distributor in Norway.

For more information, please contact:

Bergman Diagnostika AS
Phone: + 47 63 83 57 50
info@bergmandiag.no
http://www.bergmandiag.no

...
Read on

New: Check-MDR CT103 XL

The Check-MDR CT103 XL is the most comprehensive CE-IVD assay for molecular beta-lactamase testing. Building on the Check-MDR CT103, the Check-MDR CT103 XL allows for an even broader analysis of beta-lactamases in Enterobacteriaceae as well as non-fermenters.

...
Read on

Webinar: Laboratory Detection of Carbapenem-Resistant Organisms

Thursday April 17, 12:00 PM - 1:00 PM EDT / 18:00 - 19:00 CEST

Laboratory detection of carbapenem resistant organisms – the emerging role of molecular assaysto define carbapenemase producers

Presented by Prof. Neil Woodford, Head of Antimicrobial Resistance and Healthcare Associated Infections Reference Unit (AMRHAI), Public Health England

Acquired carba...

Read on

New: ASR Products

We are very pleased to announce the launch of a new product range consisting of primer sets and probes. These are manufactured under cGMP to ensure optimal consistency and quality.

Now available:

KPC Primer
KPC Probe
NDM Primer
NDM Probe 1
NDM Probe 2
VIM Primer
VIM Probe
OXA-48 Primer
OXA-48 Probe

Read on

Check-Direct CPE now for Rotor-Gene Q and LightCycler® 480 II

The Check-Direct CPE, our real-time PCR kit for detection of carbapenemases, is now compatible with two further real-time PCR systems.

The validated platforms currently include:

  • ABI 7500
  • CFX96TM
  • LightCycler® 480 I&II
  • Rotor-Gene Q

 

The assay can be performed directly from rectal or perianal ...

Read on

New: Check-MDR Carba & Check-MDR ESBL for 24 reactions

Check-MDR Carba and Check-MDR ESBL are now available in a 24 reactions as well as a 96 reactions format.
 
The Check-Points real-time PCR kits allow for accurate detection of the clinically most prevalent carbapenemases and ESBLs - in just 4.5 hours. By utilizing a standard thermal profile as well as existing real-time equipment, the assays are easily implemented in yo...
Read on

New: Real-Time detection of carbapenemases and ESBLs

We are pleased to announce the launch of Check-MDR Carba and Check-MDR ESBL - our first products based on a Real-Time detection platform.

Features & Benefits:

  • One accurate test for all clinically prevalent types
  • Objective results in 4.5 hours
  • Use in your Real-Time labflow

Read on

Meet us at the 22nd ECCMID

Learn more about our latest products. Visit our booth (#323) at the 22nd ECCMID in London 31 March-3 April.

Exhibition opening hours

Saturday, March 31st: 12:00-18:45
Sunday, April 1st: 10:00-18:30
Monday, April 2nd 10:00-18:30
Tuesday, April 3rd 10:00-13:30

Read on

Symposium: Molecular detection of ESBL and carbapenemases

When: Tuesday 13 March 2012, 12:00-18:15 with closing dinner

Venue: Grand Hotel Karel V, Geertebolwerk 1, 3511XA Utrecht

 Symposium title: Molecular detection of ESBL and carbapenemases: now and in the future

 

Final program:

To download a PDF version of the final invitation, please click Read on